Amplitude Surgical (XPAR:AMPLI) Cash-to-Debt : 0.28 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Amplitude Surgical Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Amplitude Surgical's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.28.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Amplitude Surgical couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Amplitude Surgical's Cash-to-Debt or its related term are showing as below:

XPAR:AMPLI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 0.24 Max: 0.63
Current: 0.28

During the past 13 years, Amplitude Surgical's highest Cash to Debt Ratio was 0.63. The lowest was 0.03. And the median was 0.24.

XPAR:AMPLI's Cash-to-Debt is ranked worse than
81.77% of 861 companies
in the Medical Devices & Instruments industry
Industry Median: 1.88 vs XPAR:AMPLI: 0.28

Amplitude Surgical Cash-to-Debt Historical Data

The historical data trend for Amplitude Surgical's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Amplitude Surgical Cash-to-Debt Chart

Amplitude Surgical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash-to-Debt

Get a 7-Day Free Trial

0.16

0.25

0.21

0.15

0.35

Amplitude Surgical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															0.17	0.15	0.08	0.35	0.28

Competitive Comparison of Amplitude Surgical's Cash-to-Debt

For the Medical Instruments & Supplies subindustry, Amplitude Surgical's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amplitude Surgical's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Amplitude Surgical's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Amplitude Surgical's Cash-to-Debt falls into.

Amplitude Surgical Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Amplitude Surgical's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	37.212	/	(11.255	+	95.223)
	=	0.35

Amplitude Surgical's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	31.342	/	(14.041	+	98.819)
	=	0.28

Amplitude Surgical (XPAR:AMPLI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Amplitude Surgical Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Amplitude Surgical's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplitude Surgical (XPAR:AMPLI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amplitude Surgical (XPAR:AMPLI) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

1AU:Germany

Address

11 cours Jacques Offenbach, Valence, FRA, 26000

Website

https://www.amplitude-surgical.com

Amplitude Surgical is engaged in developing and marketing products for orthopedic surgery. It offers a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities for foot and ankle surgery. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.

Amplitude Surgical (XPAR:AMPLI) Headlines

No Headlines